: . . . .

  <-> <-> <->


Fun new series sites











[ ÃÈÍÇË ] æ ÏÑÇÓÇÊ ÚáãíÉ æÈíÆíÉ research methods
ããÇÑÓÉ ÇáÑíÇÖÉ ÊÍÓä ÇáÕÍÉ
ããÇÑÓÉ ÇáÑíÇÖÉ ÊÍÓä ÇáÕÍÉ
13-09-2010 02:51

  2012




ÇáÑ*ÇÖÉ_ããÇÑÓÉ ÇáÑ*ÇÖÉ_ãÑÖ ÇáÞáÈ_ÇáÕÍÉ æ ÇáÑ*ÇÖÉ


ããÇÑÓÉ ÇáÑ*ÇÖÉ ÊÍÓä ÕÍÉ ãÑÖ* ÝÔá ÇáÞáÈ

*ßÝ* áãÑÖì ÝÔá ÇáÞáÈ Ãä *ÚãáæÇ Úáì ÇáÏÑøÇÌÉ ÇáÑ*ÇÖ*É ÇáËÇÈÊÉ Ãæ ÇáãÔ* ãä 25 Åáì 30 ÏÞ*ÞÉ Ý* Çá*æã áãÚÙã Ã*Çã ÇáÃÓÈæÚ ááÊÞá*á ãä ãÎÇØÑ ÇáÊäæ*ã Ý* ÇáãÓÊÔÝ*ÇÊ Çæ ÇáãæÊ, ßãÇ *Þæá ÇáÈÇÍËæä ãä ãÑßÒ Ï*æß ááÃÈÍÇË ÇáØÈ*É Duke Clinical Research Institute (DCRI)
åÐå ÇáäÊÇÆÌ ÅÓÊõÎáÕÊ ãä ÃßËÑ ÇáÏÑÇÓÇÊ Ôãæá*É ááÂä ÇáÊ* ÊÎÊÈÑ ÊÃË*ÑÇÊ ÇáÑ*ÇÖÉ Úáì ãÑÖì ÝÔá ÇáÞáÈ

the HF-ACTION trial (A Controlled Trial Investigating Outcomes Exercise Training), the most comprehensive study to date examining the effects of exercise upon patients with heart failure. The study, led by Christopher O’Connor M.D., director of the Duke Heart Center and principal investigator of the trial, and David Whellan, M.D., of Thomas Jefferson University, co-principal investigator, appears in the April 8 issue of the Journal of the American Medical Association
ÔÇÑß Ý* ÇáÏÑÇÓÉ 2,331 ãÑ*Ö Ý* 82 ãæÞÚ ÏÑÇÓ* Ý* ÇáæáÇ*ÇÊ ÇáãÊÍÏÉ ÇáÃãÑ*ß*É æßäÏÇ æÝÑäÓÇ. æÊãóø ÊæÒ*Ú ÇáãÑÖì ÚÔæÇÆ*Çð Úáì
ãÌãæÚÉ ÊÊáÞøì ÇáÑÚÇ*É ÇáãõÚÊÇÏÉ, Ãæ

ãÌãæÚÉ ÊÊáÞøì ÇáÑÚÇ*É ÇáãÚÊÇÏÉ ÈÇáÅÖÇÝÉ Åáì ÈÑäÇãÌ ããÇÑÓÉ Ñ*ÇÖÉ *ÈÏà ãÚ ãõÔÑÝ Ñ*ÇÖÉ æ*äÊÞá áÇÍÞÇð Ý* ÇáÈ*Ê ÈÚãá Ñ*ÇÖÉ æãÊÇÈÚÉ ÔÎÕ*É
ßÇä ááÈÇÍË*ä äÙÑ*É Ãä ããÇÑÓÉ ÇáÑ*ÇÖÉ Öãä ÈÑäÇãÌ Ó*ÍÞøÞ ÅäÎÝÇÖ ãÚäæ* Ý* ãõÚÏøáÇÊ ÇáÅÏÎÇá áÅáì ÇáãÓÊÔÝ*ÇÊ æÇáãæÊ áãÑÖì ÝÔá ÇáÞáÈ, æáßä ÈÚÏ ÊÍá*á ÇáÈ*ÇäÇÊ ÇáÃæá*É æÌÏ ÇáÈÇÍËæä ÅäÎÝÇÖ ãÊæÓØ ÝÞØ æÛ*Ñ ãÚäæ* áãõÚÏøáÇÊ ÇáÅÏÎÇá ááãÓÊÔÝ*ÇÊ Çæ ÇáãæÊ
Úáì ßá ÍÇá, ÝÅä ÇáÈÇÍËæä æÌÏæÇ ÈÚÏ ÅÌÑÇÁ ÊÍá*á ËÇäæ* ãõÎØøØ ÂÎÐ*ä Ý* ÇáÍÓÈÇä ÇáÚæÇãá ÇáÅßá*ä*ß*É ÇáÞæ*É ÇáÊ* ÊõäÈìÁ ÈÇáÅÏÎÇá ááãÓÊÔÝ*ÇÊ Ãæ ÇáãæÊ, æÌÏæÇ Ãä ááÑ*ÇÖÉ ÝÇÆÏÉ ãÚäæ*É

æ*Ããá ÇáÈÇÍËæä Ãä ÊÖÚ åÐå ÇáäÊÇÆÌ ãÎÇæÝ ãä Ãä Êßæä ããÇÑÓÉ ÇáÑ*ÇÖÉ ÎØÑÉ Úáì ãÑÖì ÝÔá ÇáÞáÈ ÌÇäÈÇð. *Þæá “ÃæßæäæÑ”: “ ãä Ãåã äÊÇÆÌ åÐå ÇáÏÑÇÓÉ, Ãä ÇáÑ*ÇÖÉ Ãã*äÉ ááãÑÖì ÇáãÕÇÈæä ÈÝÔá ÇáÞáÈ, æãÚ ÊÚÏ*á ãæÇÕÝÇÊ ÃÓÇÓ*É ãÚ*äÉ *ãßä ÊÍÓ*ä ÇáäÊÇÆÌ ÇáØÈ*É ÇáÅßá*ä*ß*É”

ÈÏà ÇáãÑÖì ÇáãÔÇÑßæä Ý* åÐå ÇáÏÑÇÓÉ, ÈÏÃæÇ ããÇÑÓÉ ÇáÑ*ÇÖÉ ÊÏÑ*Ì*Çð æåÏÝåã ÇáæÕæá Åáì ããÇÑÓÉ ÇáÑ*ÇÖÉ áËáÇË*ä ÏÞ*ÞÉ Ý* ÇáÌáÓÉ ÇáæÇÍÏÉ æáËáÇË ãÑøÇÊ Ý* ÇáÃÓÈæÚ. æÈÚÏ 18 ÌáÓÉ, ÅäÊÞáæÇ áããÇÑÓÉ ÇáÑ*ÇÖÉ Ý* ÇáÈ*Ê ÈåÏÝ ÇáæÕæá Åáì ããÇÑÓÉ ÇáÑ*ÇÖÉ áÃÑÈÚ*ä ÏÞ*ÞÉ Úáì ÇáÓ*Ñ ÇáãÊÍÑß Ãæ ÇáÏÑøÇÌÉ ÇáËÇÈÊÉ áãÏÉ ÎãÓÉ Ã*Çã Ý* ÇáÃÓÈæÚ. æÍÇÝÙ ÇáãÑÖì Úáì ÓÌáÇøÊ ããÇÑÓÉ ÇáÑ*ÇÖÉ Çá*æã*É æãõÚÏøáÇÊ ÖÑÈÇÊ ÇáÞáÈ
ÊÇÈÚ ÇáÈÇÍËæä ÇáãÑÖì ÈãÊæÓØ ÓäÊ*ä æäÕÝ ÇáÓäÉ ãõÓÌá*ä ÇáÞ*ÇÓÇÊ ÇáÅßá*ä*ß*É ÇáãÎÊáÝÉ áãÑÖì ÝÔá ÇáÞáÈ æÌæÏÉ ÇáÍ*ÇÉ æÇáÅÏÎÇá ááãÓÊÔÝì æÇáÊÚÑõøÖ áãÔÇßá ÇáÞáÈ æãõÚÏøáÇÊ ÇáæÝ*ÇÊ

ÊÞæá ÇáÏßÊæÑÉ Ãá*ÒÇÈË äÇÈá, ãÏ*ÑÉ ÇáãÚåÏ ÇáæØä* ááÞáÈ æÇáÑÆÉ æÇáÏã: “áåÐå ÇáÏÑÇÓÉ Ãåã*É ßÈ*ÑÉ áæÌæÏ 5 ãáÇ**ä ÃãÑ*ß* áÏ*åã ÝÔá ÇáÞáÈ. æÍ*Ë Ãäå ãä ÇáãÊæÞÚ Ò*ÇÏÉ ÃÚÏÇÏ ãÑÖì ÝÔá ÇáÞáÈ Öãä ÓßÇä ÇáæáÇ*ÇÊ ÇáãÊÍÏÉ ÇáÃãÑ*ß*É, ÝÅäå ãä Çáãåã ãÚÑÝÉ Ãä ÇáãÑÖÉ *ÓÊÝ*Ïæä ãä æÓ*áÉ ÐÇÊ ãÎÇØÑ ãäÎÝÖÉ áÊÍÓ*ä ÕÍÊåã”



0 | 0 | 1977 |


       ♥

  • :
  • []
  • []
  • []
  • []
  • []


ÚÇÔÞÉ ÇáÝÑÏæÓ
4.25/10 (3 )


Powered by Dimofinf cms Version 3.0.0
Copyright© Dimensions Of Information Inc.

:
ǡ

Privacy policy